Atlas Trials

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia

Clinical trial NCT04373941 · UNKNOWN

Trial details

NCT number
NCT04373941
Sponsor
Holterman, Ai-Xuan, M.D.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Atresia
Start date
2023-09-01
Primary completion
2024-08-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.